ASFH Anecortave vs Verteporforin
As Seen From Here by Joshua A Young, MD
Episode notes
Paper Discussed: Slakter JS, Bochow TW, D'Amico DJ, Marks B, Jerdan J, Sullivan EK, Robertson SM, Slakter JS, Sullins G, Zilliox P; Anecortave Acetate Clinical Study Group
Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration
Ophthalmology. 2006 January;113(1):p3-13
Guest: Jason Slakter, MD
Clinical Professor of Ophthalmology
New York University School of Medicine
New York, New York
Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration
Ophthalmology. 2006 January;113(1):p3-13
Guest: Jason Slakter, MD
Clinical Professor of Ophthalmology
New York University School of Medicine
New York, New York